Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature
Tasha Kulai(Dalhousie University), John Igoe(Dalhousie University), Thomas Arnason(Dalhousie University), Donald MacIntosh(Dalhousie University)
Cited by 10
Related Papers
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
|The Lancet|2015|462
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
|Thrombosis Research|2005|194
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary Surgery
|JAMA Oncology|2019|117
Esophageal-guided biopsy with volumetric laser endomicroscopy and laser cautery marking: a pilot clinical study
|Gastrointestinal Endoscopy|2014|106
Collagenous gastritis: a morphologic and immunohistochemical study of 40 patients
|Modern Pathology|2014|101